AstraZeneca, UNICEF Launch Five-Year Adolescent Health Program, $100M+ Through 2030

The scale here is as much organizational as financial: sixty NGOs across more than sixty countries implies a coordination burden that corporate-philanthropic programs often underestimate, and UNICEF's involvement gives the effort a distribution footprint AstraZeneca could not build alone. For the company, this sits closer to long-term reputational and access positioning than to any near-term commercial line. The open question is whether the five-year framing translates into measurable health outcomes rather than renewed commitments, since cumulative spending targets say little about delivery.